Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,786.00
Bid: 4,786.00
Ask: 4,788.00
Change: 10.00 (0.21%)
Spread: 2.00 (0.042%)
Open: 4,826.00
High: 4,842.00
Low: 4,766.00
Prev. Close: 4,776.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outsourcing contract

15 May 2006 14:05

Intertek Group PLC15 May 2006 15 May 2006, 2pm (UK) Intertek Group plc ("Intertek") Intertek in discussions on an outsourcing deal with Chemelot Intertek, the international provider of quality and safety services to a widerange of industries, announces that its Oil, Chemical and Agri division iscurrently in discussions with Chemelot BV on the outsourcing of an analyticalchemical testing laboratory in Geleen, Netherlands. Chemelot BV is a subsidiaryof DSM N.V. Consultations have commenced with the works council and trade unionsas provided for by European Union and Dutch law. A further announcement relating to this outsourcing contract will be made in duecourse. ABOUT INTERTEKIntertek is a leading international provider of quality and safety services to awide range of global and local industries. Partnership with Intertek bringsincreased value to customers' products, processes and ultimately supports theirsuccess in the global market place. Intertek has the experience, expertise,resources and global reach to support their customers through their network ofover 850 laboratories and offices, 15,500 people in more than 100 countriesaround the world. ABOUT CHEMELOTIn the field of investments for the chemical industry Chemelot is an importantbusiness partner in Western Europe. Furthermore Chemelot is an innovativechemical community, with an excellent infrastructure and perfect logistics viawater, rail and road. The Chemelot community in Geleen has all ingredients forso called accelerated business growth, driven by new investments in researchactivities; all kind of new start-ups and an innovative open campus. In manydifferent ways Chemelot has a high added value in realizing innovative plans andinvestments in chemical activities. ABOUT DSMDSM is active worldwide in nutritional and pharma ingredients, performancematerials and industrial chemicals. The company creates innovative products andservices that help improve the quality of life. DSM's products are used in awide range of end markets and applications such as human and animal nutritionand health, cosmetics, pharmaceuticals, automotive and transport, coatings,housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 -Building on Strengths, focuses on accelerating profitable and innovative growthof the company's specialties portfolio. Market-driven growth, innovation andincreased presence in emerging economies are key drivers of this strategy. Thegroup has annual sales of over EUR 8 billion and employs some 22,000 peopleworldwide. DSM ranks among the global leaders in many of its fields. The companyis headquartered in the Netherlands, with locations in Europe, Asia, Africa andthe Americas. ENQUIRIES: INTERTEKAston Swift, Investor Relations IntertekTelephone: +44 (0) 20 7396 3400Aston.swift@intertek.com Richard Mountain, Financial DynamicsTelephone: +44 (0) 20 7831 3113Richard.mountain@fd.com Internet: www.intertek.com High-resolution images of Intertek Group plc businesses are available todownload, free of charge from www.vismedia.co.uk. CHEMELOT AND DSMGerard van der Zanden, Communications Chemelot and DSMTelephone: +31 (0) 46 47 64077Gerard.zanden-van-der@dsm.comInternet: www.chemelot.nl and www.dsm.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th May 20241:00 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSDirectorate Change
24th May 20241:30 pmRNSResult of AGM
24th May 20247:00 amRNSTrading Statement
22nd May 20241:00 pmRNSBlock listing Interim Review
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.